ABSTRACT We studied 25 adolescent and adult patients with cystic fibrosis (CF) 
An increased prevalence of atopy in patients with cystic fibrosis (CF) was first reported by Lowe in 1949.1 Since that time, a number of authors studying a variety of atopic indices have published results, some confirming the association,2-6 others disputing it. [7] [8] [9] Because of these conflicting results, and because of the difference in methodology used to assess atopy, we undertook a study to define the prevalance of atopy in a group of adolescents and young adults with CF, by examining a comprehensive range of atopic indices. Furthermore, we carried out HLA phenotyping to determine if those CF patients with atopic features constituted a separate.
genetically linked subgroup.
The related problem of bronchial reactivity was studied by spirometric measurements before Presented in part at the Joint Thoracic Society and British Thoracic Association Meeting, February 1980. and after inhalation challenge with a bronchoconstrictor, histamine, and two bronchodilators, a beta2 adrenergic agonist, fenoterol, and a parasympatholytic, ipratropium bromide.
Methods
Twenty-five documented CF patients, with an age range from 10 to 32 years (mean 17 yr) were studied. A control group consisted of 25 healthy individuals, with an age range from 10 to 28 years (mean 15-2 yr). The male-female ratio was identical in each group (2 1:1). The patients were divided into three groups of severity on the basis of clinical and radiological findings.'0 Consent to carry out the study was obtained from parents of all subjects under 18 years of age.
ALLERGIC PROFILE
Both patients and control subjects were questioned about a history of wheezing, allergic rhinitis, eczema, "hives", angioneurotic oedema, drug allergy, nasal polyposis, and a family history of allergy. Skin hypersensitivity tests were performed with a diluent control, a positive control (histamine add phosphate), and the following 13 
Results
The results of the atopic questionnaire are shown in table 1 . All atopic features were reported more commonly in the CF patients, including a marked increase in the reported prevalence of such features in their first degree relatives.
ALLERGIC PROFILE
The CF group had significantly more positive skin tests than the control subjects, 88% compared with 36% (p<0-001) and the mean number of reactions per individual, 5-5 and 1-5 respectively, was also significantly higher (p<0-001). Both groups were similar in having the greatest number of positive reactions to house-dust, but the CF group had a far greater number of reactions to the fungal antigens -A fumigatus, A terreus, C herbarum, and a group of mixed moulds (table 2). The two groups showed Serum immunoglobulin E was increased above 100 U/ml in 46% of the CF patients, compared with 21% of the control subjects (figure) and the mean level was significantly higher in the former group (p<0 01). Total blood eosinophil count was elevated above 400 cells/mm3 in 33% of the CF subjects compared with 16% of the controls, and the mean count in the former was higher (375/mm3 and 268/mm3 respectively), although this difference did not reach statistical significance. Similarly, mean serum IgG4 was significantly higher in the CF patients than the control group (p<0 001, figure) . A significant correlation between the subject's age and the level of IgG4 was found in the CF patients ( The results of bronchodilator administration in the CF group are set out in table 4 . After ipratropium bromide, a greater than 15% rise in PEFR, FEV1, and FVC occurred in 32%, 23%, and 27% respectively. The patient group as a whole showed a mean percent rise in PEFR, FEV1, and FVC of 8-2%, 7*5%, and 8-9%, and a mean absolute rise of 22 1/min, 125 ml, and 174 ml respectively.
Inhalation of fenoterol induced a greater than 15% rise in PEFR, FEV1, and FVC in 27%, 14%, and 18% of the patients, with a mean percentage rise of 12-2%, 9-6%, and 11-9%, and a mean absolute rise of 28 1/min, 193 ml, and 225 ml respectively.
GRADING OF DISEASE SEVERITY
The patients were divided into three groups in increasing order of severity: group 1 consisted of 10 patients, group 2 of six, and group 3 of nine. In these three small subgroups, it was not possible to relate clearly the severity of disease with the number of atopic features present, or the degree of bronchial reactivity.
Discussion
This comprehensive study of atopic indices in CF, has permitted us to confirm and extend previous observations on this association. Our CF patients, compared with control subjects, demonstrated a striking prevalence of atopic features as judged by prick testing of the skin, total serum IgE levels, total eosinophil counts, serum IgG4 levels, and an atopic questionnaire. The related problem of bronchial reactivity has been similarly defined in more detail, using a variety of bronchoconstrictor and bronchodilator challenges. Comparing our data with results of previous studies, interesting differences and similarities are noted.
Positive skin tests were observed more frequently in the CF group than in the control group, 88% and 36% respectively, and the former also had significantly more reactions per individual. In contrast to the previous reports of a relatively low frequency of reactions to housedust and house-dust mite in CF patients,6 14 15 they produced the greatest number of positive reactions in our patients. The increased sensitivity to house-dust and house-dust mite noted in our patients may reflect the fact that they were older than the patients in other studies. This is in accordance with the results of another study of ours '6 The reason for the increased prevalence of atopy in CF is unknown. One possibility is that the phenomenon is acquired as a result of increased antigen access to the IgE producing cells in the submucosa. Mechanisms which might be responsible include abnormal mucosal permeability, a defective secretory IgA system,23 trapping of antigen in infected areas of the lung, or failure of antigen clearance because of a ciliotoxic factor. An alternative explanation is that there is a genetic linkage between the CF gene and genes controlling atopic response. In our study, there was a significantly increased family history of atopy in the CF group. However, one must have reservations about comparisons between historical data derived from frequently interviewed patients, and those obtained from healthy control subjects. Although Warner24 found an increased personal history of atopy and positive skin tests in a study of obligate heterozygotes, a separate study of ours'6 suggests that there is no significant difference between positive skin tests in obligate heterozygotes and control subjects. In view of Soothill's25 finding of an increased prevalence of HLA-A1 and B8 among infants with positive skin tests, we examined the HLA phenotype pattern of our patients, but failed to detect linkage of atopy to any particular HLA antigen.
The frequent association of bronchial hyperreactivity with atopy has led a number of investigators to study the response to inhaled bronchoconstrictors and bronchodilators in CF.
Haluszka26 and Mellis27 performed bronchial provocation in CF, using varying doses of histamine, and found a positive response in 68% and 24% respectively. In contrast, we used a fixed dose of histamine (400 , 
